Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
60 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BIOMEDICAL DIAGNOSTICS from Antwerpen, company number BE0479414976, closed financial year 2025 with a result of € 339,858 after tax. For that financial year BIOMEDICAL DIAGNOSTICS recorded a gross margin of € 1.3 million and equity of € 2.5 million. Compared with financial year 2024, the result moved from € 378,092 to € 339,858. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 2.5 million
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 339,858
▼ 10% vs 2024
Profit after tax over the fiscal year.
€ 501,391
▼ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.4 million.
People and assets in 2025
7.4
▲ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 949,521
▲ 13% vs 2024
€ 128,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 828,369
▲ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 214,603
▼ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,541,376 | € 1,445,326 | € 1,370,713 | € 1,304,195 | ▼ 5% |
| Profit after taxes | € 590,228 | € 603,045 | € 378,092 | € 339,858 | ▼ 10% |
| Equity | € 1,148,508 | € 1,751,553 | € 2,129,644 | € 2,469,502 | ▲ 16% |
| Total debts | € 493,990 | € 796,540 | € 832,551 | € 1,048,949 | ▲ 26% |
| Cash | € 599,399 | € 1,218,556 | € 694,724 | € 501,391 | ▼ 28% |
| Retained profit | € 1,086,508 | € 1,689,553 | € 2,067,644 | € 2,407,502 | ▲ 16% |
| Balance sheet total | € 1,690,498 | € 2,596,093 | € 3,010,195 | € 3,518,451 | ▲ 17% |
| Employees (FTE) | 5.3 | 5.8 | 6.7 | 7.4 | ▲ 0.7 |
Key figures of BIOMEDICAL DIAGNOSTICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOMEDICAL DIAGNOSTICS?
What happened at BIOMEDICAL DIAGNOSTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Steens Management BV stepped down as director. NBB
- Olivier Bosc stepped down as director. NBB
- Eurobio Scientific SA stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 339,858 (▼ 10% vs 2024). Source: NBB ↗
- Olivier Bosc became a director. NBB
- Steens Management BV became a director. NBB
- Eurobio Scientific SA became a director. NBB
- New establishment in Antwerpen. KBO
In short
From € 590,228 profit in 2022 to € 339,858 profit in 2025.
Paid € 670,791 in corporate taxes since 2022.
Best year ever: 2023, with € 603,045 profit.
On average € 176,200 of value added per employee in 2025.
A new publication or filing at BIOMEDICAL DIAGNOSTICS? We notify you, reason included.
Follow BIOMEDICAL DIAGNOSTICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Eurobio Scientific Benelux comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BIOMEDICAL DIAGNOSTICSThe shares are held by Eurobio Scientific Benelux (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by Fabienne Steens
since 2022 · until 2028
Olivier Bosc
Director
since 2025 · until 2028
Eurobio Scientific SA
Director · represented by Denis Fortier
Also active at: Eurobio Scientific Benelux
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorderlaan 139
2030 Antwerpen
Noorderlaan 139 box 3V
2030 Antwerpen
Active since 25 February 2003
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 60 companies are registered at this address.
All companies at this address →Lykes Bros Belgium
Scheepswerf De Toekomst
Waste Disposal Systems
AXE INVESTMENTS/ SEA LLOYD
€ 869,348 revenue · 2025
STRABAG Development Belgium
+55 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
NL-BIT BIT BV, NL
Website info
Features
Security
Network
Details
- Company number
- 0479.414.976
- VAT number
- BE 0479.414.976
- Registered office
- Noorderlaan 139, 2030 Antwerpen
- Names & denominations
- BIOMEDICAL DIAGNOSTICS · BMD
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 January 2003
- Peppol
- Active · Active since 21 Jan 2026
- Contact
- bmd.be
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen